Yang, C.; Liu, P. pH/GSH co-triggered degradable polyprodrug as drug self-delivery system for tumor-specific doxorubicin delivery: effect of aggregation states. Chinese J. Polym. Sci. https://doi.org/10.1007/s10118-025-3340-8
Chen Yang, Peng Liu. pH/GSH Co-triggered Degradable Polyprodrug as Drug Self-delivery System for Tumor-specific Doxorubicin Delivery: Effect of Aggregation States[J/OL]. Chinese journal of polymer science, 2025, 431-7.
Yang, C.; Liu, P. pH/GSH co-triggered degradable polyprodrug as drug self-delivery system for tumor-specific doxorubicin delivery: effect of aggregation states. Chinese J. Polym. Sci. https://doi.org/10.1007/s10118-025-3340-8DOI:
Chen Yang, Peng Liu. pH/GSH Co-triggered Degradable Polyprodrug as Drug Self-delivery System for Tumor-specific Doxorubicin Delivery: Effect of Aggregation States[J/OL]. Chinese journal of polymer science, 2025, 431-7. DOI: 10.1007/s10118-025-3340-8.
pH/GSH Co-triggered Degradable Polyprodrug as Drug Self-delivery System for Tumor-specific Doxorubicin Delivery: Effect of Aggregation States
Numerous efforts have been devoted to altering the dynamic covalent linkers between the drug structural units in polyprodrugs from the viewpoint of molecular structure; however
the effect of their aggregation states has not yet been explored. Here
the effect of aggregation states on the
in vitro
drug release and cytotoxicity was investigated using a pH/GSH co-triggered degradable doxorubicin (DOX)-based polyprodrug (PDOX) as a model
which was synthesized by the facile polymerization of a pH/GSH dual-triggered dimeric prodrug (DDOX
ss
) and 2
2-dimethoxypropane (DMP) by forming acid-labile ketal bond. Owing to the pH/GSH dual-triggered disulfide/
α
-amide and acid-labile ketal linkers between the DOX structural units
the resultant PDOX exhibited excellent pH/GSH co-triggered DOX release. With a similar diameter
the PDOX-NPs1 nanomedicines
via
fast precipitation showed faster DOX release than PDOX-NPs2
via
slow self-assembly
regardless of their polymerization degree (DP). The effect of aggregation states is expected to be a secondary strategy for a more desired tumor intracellular microenvironment-responsive drug delivery for tumor chemotherapy
in addition to the molecular structures of polyprodrugs as drug self-delivery systems (DSDSs).
关键词
Keywords
references
Alex, J.; Weber, C.; Guerrero-Sanchez, C.; Schubert, U. S. Recent developments in synthetic approaches for macro molecular prodrugs. Prog. Polym. Sci. 2024 , 155 , 101855..
Girase, M. L.; Patil, P. G.; Ige, P. P. Polymer-drug conjugates as nanomedicine: a review. Int. J. Polym. Mater. Polym. Biomater. 2020 , 69 , 990−1014..
Qin, S. Y.; Zhang, A. Q.; Cheng, S. X.; Rong, L.; Zhang, X. Z. Drug self-delivery systems for cancer therapy. Biomaterials 2017 , 112 , 234−247..
Liu, P. Polyprodrugs for tumor chemotherapy: from molecular structure to drug release performance. J. Mater. Chem. B 2023 , 11 , 9565−9571..
Lin, C.; Liang, Y. X.; Guo, M. Y.; Saw, P. E.; Xu, X. D. Stimuli-responsive polyprodrug for cancer therapy. Mater. Today Adv. 2022 , 15 , 100266..
Li, X. M.; Liu, P. Synthesis and self-assembly of an acid/reduction co-triggered degradable amphiphilic copolyprodrug as a tumor-selective drug self-delivery system. J. Mater. Chem. B 2022 , 10 , 2926−2932..
Li, X.M.; Zhang, J.; Liu, P. Facile one-pot synthesis of amphiphilic acid/hypoxia co-triggered degradable diblock polyprodrug for tumor selective drug delivery. Int. J. Pharm. 2021 , 606 , 120941..
Li, J. G.; Liu, P. pH/Reduction dual-triggered degradable poly(doxorubicin) prodrug nanoparticles for leakage-free tumor-specific self-delivery. Macromol. Rapid Commun . 2018 , 39 , 1800381..
Yang, C.; Liu, P. Disulffde/ α -amide-bridged doxorubicin dimeric prodrug: effect of aggregation structures on pH/GSH dual-triggered drug release. Langmuir 2024 , 40 , 11098−11105..
Yang, C.; Liu, P. Regulating drug release performance of acid-triggered dimeric prodrug-based drug self-delivery system by altering its aggregation structure. Molecules 2024 , 29 , 3619..
Yang, C.; Liu, P. Structural aspects of dimeric prodrug-based carrier-free nanomedicines for tumor chemotherapy. J. Mater. Chem. B 2025 , 13 , 3292−3294..
Gillies, E. R.; Frechet, J. M. J. pH-Responsive copolymer assemblies for controlled release of doxorubicin. Bioconjugate Chem . 2005 , 16 , 361–368..
Missirlis, D.; Kawamura, R.; Tirelli, N.; Hubbell, J. A. Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur. J. Pharm. Sci. 2006 , 29 , 120−129..
Zhang, P.; Li, J.; Ghazwani, M.; Zhao, W. C.; Huang, Y. X.; Zhang, X. L.; Venkataramanan, R.; Li, S. Effective co-delivery of doxorubicin and dasatinib usinga PEG-Fmoc nanocarrier for combination cancer chemotherapy. Biomaterials 2015 , 67 , 104−114..
Lee, J.; Kim, J.; Lee, Y. M.; Park, D.; Im, S.; Song, E. H.; Park, H.; Kim, W. J. Self-assembled nanocomplex between polymerized phenylboronic acid and doxorubicin for efficient tumor-targeted chemotherapy. Acta Pharm. Sin . 2017 , 38 , 848–858..
Li, J.; Yang, C.; Zhou, P. P.; Liu, P. Effect of aggregation structures of dimeric prodrug-based carrier-free nanomedicines for tumor chemotherapy. Colloid Surf. A-Physicochem. Eng. Aspects 2024 , 693 , 134044..
Wang, T.; Jin, M.; Chen, Z. L.; Hu, X. J.; Pu, L.; Pei, Z. C.; Pei, Y. X. Tumor microenvironment responsive supramolecular glyco-nanovesicles based on diselenium-bridged pillar[5 ] arene dimer for targeted chemotherapy. Chem. Commun. 2020 , 56 , 10642−10645..
Zhao, X. M.; Liu, P. Synthesis of amphiphilic pH-responsive doxorubicin and ferrocene-containing copolyprodrug as drug self-delivery system and its in vitro synergistic apoptosis and ferroptosis tumor therapy. Chinese J. Polym. Sci. 2025 , 43 , 10.1007/s10118−025-3316-8..
Huang, Y. K.; Tian, H.-R.; Zhang, M. Z.; He, J. L.; Liu, J.; Ni, P. H. Monoclonal antibody-conjugated polyphosphoester-hyd-DOX prodrug nanoparticles for targeted chemotherapy of liver cancer cells. Chinese J. Polym. Sci. 2021 , 39 , 1392−1402..
Tumor-Penetrating and Mitochondria-Targeted Drug Delivery Overcomes Doxorubicin Resistance in Lung Cancer
Related Author
Xiao-Mei Zhao
Rui Dou
Meng-Xue Zhou
Jia-Yu Zhang
Xiao-Meng Cai
Li-Fo Ruan
Wen-Jiang Yang
Wen-Chu Lin
Related Institution
High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China, University of Science and Technology of China
Division of Nuclear Technology and Applications, Institute of High Energy Physics, Chinese Academy of Sciences (CAS)
Key Laboratory of Tea Biology and Resource Utilization of Ministry of Agriculture, Tea Research Institute, Chinese Academy of Agricultural Sciences
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics and University of Chinese Academy of Sciences (UCAS), Chinese Academy of Sciences (CAS)
School of Biomedical Engineering, Sun Yat-sen University